Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples